Submission Details
| 510(k) Number | K231370 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 12, 2023 |
| Decision Date | August 04, 2023 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Obstetrics & Gynecology (OB) |
| Summary | Summary PDF |
K231370 is an FDA 510(k) clearance for the Dewin Blastocyst Medium (with HSA and without HSA), a Media, Reproductive (Class II — Special Controls, product code MQL), submitted by Donnevie Medical Technology (Shanghai) Co. , Ltd. (Shanghai, CN). The FDA issued a Cleared decision on August 4, 2023, 84 days after receiving the submission on May 12, 2023. This device falls under the Obstetrics & Gynecology review panel. Regulated under 21 CFR 884.6180.
| 510(k) Number | K231370 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 12, 2023 |
| Decision Date | August 04, 2023 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Obstetrics & Gynecology (OB) |
| Summary | Summary PDF |
| Product Code | MQL — Media, Reproductive |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 884.6180 |